As a wholly owned subsidiary of Syscore GmbH, Codialist GmbH was spun off from Berlin Heart GmbH in April 2020 as a sister company. With its extensive know-how in the development and life cycle management of medical device software for all safety classes for the products of Berlin Heart, Codialist is now offering this service to other medical technology and diagnostic companies.

From their extensive experience, “Codialists” are well aware of the technical hurdles and normative challenges encountered when realizing complex innovations. This has allowed them to quickly develop a deep understanding of the broadest range of product requirements.

Their deliverables, which include embedded software, complex algorithms for control and diagnostics, and graphical user interfaces, can meet the stringent requirements of CE certification and FDA approval. Because the Codialists use qualified state-of-the-art tools that are highly automated, they are able to verify software and software changes in the shortest of times.

"We would like to share our knowledge, experience and passion with specialists who, like us, implement innovations in medical technology in order to sustainably improve people’s lives," says Sven-René Friedel, Managing Director of CODIALIST GmbH.

With this calling, the Codialist experts developed the software for the new mobile driving unit EXCOR® Active for Berlin Heart GmbH. Among other things, this software regulates a safe pump functioning, monitors the electronic and mechanical components, and provides an intuitive user interface. The close coordination with project participants and a strong network have been crucial for the success of this project and will bring great advantages for future projects.

Learn more about us at: www.codialist.de

Über die Berlin Heart GmbH

Berlin Heart GmbH develops, manufactures, and markets innovative ventricular assist devices (VADs) for mechanical circulatory support. With the EXCOR® Adult and the EXCOR® Pediatric, Berlin Heart is the only company in the world able to provide support to patients of every age and size, from infants to adults.

Berlin Heart’s systems provide left ventricular, right ventricular, or biventricular support (both sides); hospitals around the world use the system for short-, medium-, and long-term circulatory support, providing patients with a life-saving treatment option.

Users can also access round-the-clock medical and technical support.

The access to some or all shown products may be restricted by country-specific regulatory approvals. The use of EXCOR® VAD for adults, RVAD-support, Excor mobile and EXCOR® Active is not FDA-approved.

Firmenkontakt und Herausgeber der Meldung:

Berlin Heart GmbH
Wiesenweg 10
12247 Berlin
Telefon: +49 (30) 8187-2600
Telefax: +49 (30) 8187-2601
http://www.berlinheart.de

Ansprechpartner:
Sandra Zürner
Marketing & Public Relations
Telefon: +49 (30) 8187-2600
E-Mail: sandra.zuerner@berlinheart.de
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel